Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma. Read more about Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial. Read more about CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Read more about Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma. Read more about Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma.
Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma. Read more about Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma.
Significance of the Pee-Value: Relevance of 24-hour urine studies for patients with myeloma Read more about Significance of the Pee-Value: Relevance of 24-hour urine studies for patients with myeloma
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Read more about EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Primary CNS lymphoma: update on molecular pathogenesis and therapy. Read more about Primary CNS lymphoma: update on molecular pathogenesis and therapy.
Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma. Read more about Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma.
Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis. Read more about Treatment-related toxicities associated with hospitalization in children, adolescents, and young adults with acute lymphoblastic leukemia: population level analysis.
